FDA Releases Draft Guidance On Improved Drug Labels

Law360, New York (April 23, 2013, 6:41 PM EDT) -- The U.S. Food and Drug Administration on Tuesday released a draft guide document setting out its suggested label design for prescription drugs and biologics, a move the agency said was designed to cut medication errors by patients, caretakers and medical staff.

According to the agency, the draft sets out suggestions for how manufacturers of prescription drugs and biologics — including both branded- and generic-drug makers — should set out critical safety details and other information on drug container and carton labels, in an effort to improve...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.